论文成果
Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
  • 点击次数:
  • 发表刊物:Toxicology and applied pharmacology
  • 文献类型:J
  • 卷号:466
  • 页面范围:116490
  • ISSN号:0041-008X
  • 关键字:Drug-drug interaction; In vitro-in vivo extrapolation; Ripretinib; UDP-glucuronosyltransferase

上一条: Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis.

下一条: Higher risk of hepatotoxicity associated with cabozantinib in cancer patients